Filtered By:
Cancer: Squamous Cell Carcinoma
This page shows you your search results in order of relevance. This is page number 17.
Order by Relevance | Date
Total 20315 results found since Jan 2013.
Investigating whether exosomal miR-205-5p derived from tongue squamous cell carcinoma cells stimulates the angiogenic activity of HUVECs by targeting AMOT
CONCLUSION: Exo-miR-205-5p derived from TSCC regulates the angiogenic activity of HUVECs by targeting AMOT and might be a new molecular target for the development of anti-vascular drugs for TSCC.PMID:37545216 | DOI:10.3233/CBM-220350
Source: Cancer Biomarkers : Section A of Disease Markers - August 7, 2023 Category: Cancer & Oncology Authors: Wenxi Huang Zanwen Zeng Yonghui Xu Zhibin Mai Source Type: research
Use of sirolimus as an adjuvant therapy for kidney transplant recipients with high-risk cutaneous squamous cell carcinomas: a prospective non-randomized controlled study
CONCLUSIONS: This study suggests that sirolimus monotherapy may be useful as adjuvant therapy of high-risk cSCC in kidney transplant recipients. The conversion strategy used was well tolerated and safe regarding key mid-term transplant outcomes.PMID:37565728 | DOI:10.1590/2175-8239-JBN-2023-0013en
Source: Jornal Brasileiro de Nefrologia - August 11, 2023 Category: Urology & Nephrology Authors: Marina Rezende de F ázio Marina Pontello Cristelli Jane Tomimori Carlos Eiji Koga Mar ília Marufuji Ogawa Giovanni Tani Beneventi Helio Tedesco-Silva Jos é Medina-Pestana Source Type: research
Investigating whether exosomal miR-205-5p derived from tongue squamous cell carcinoma cells stimulates the angiogenic activity of HUVECs by targeting AMOT
CONCLUSION: Exo-miR-205-5p derived from TSCC regulates the angiogenic activity of HUVECs by targeting AMOT and might be a new molecular target for the development of anti-vascular drugs for TSCC.PMID:37545216 | DOI:10.3233/CBM-220350
Source: Cancer Biomarkers : Section A of Disease Markers - August 7, 2023 Category: Cancer & Oncology Authors: Wenxi Huang Zanwen Zeng Yonghui Xu Zhibin Mai Source Type: research
Use of sirolimus as an adjuvant therapy for kidney transplant recipients with high-risk cutaneous squamous cell carcinomas: a prospective non-randomized controlled study
CONCLUSIONS: This study suggests that sirolimus monotherapy may be useful as adjuvant therapy of high-risk cSCC in kidney transplant recipients. The conversion strategy used was well tolerated and safe regarding key mid-term transplant outcomes.PMID:37565728 | DOI:10.1590/2175-8239-JBN-2023-0013en
Source: Jornal Brasileiro de Nefrologia - August 11, 2023 Category: Urology & Nephrology Authors: Marina Rezende de F ázio Marina Pontello Cristelli Jane Tomimori Carlos Eiji Koga Mar ília Marufuji Ogawa Giovanni Tani Beneventi Helio Tedesco-Silva Jos é Medina-Pestana Source Type: research
Investigating whether exosomal miR-205-5p derived from tongue squamous cell carcinoma cells stimulates the angiogenic activity of HUVECs by targeting AMOT
CONCLUSION: Exo-miR-205-5p derived from TSCC regulates the angiogenic activity of HUVECs by targeting AMOT and might be a new molecular target for the development of anti-vascular drugs for TSCC.PMID:37545216 | DOI:10.3233/CBM-220350
Source: Cancer Biomarkers : Section A of Disease Markers - August 7, 2023 Category: Cancer & Oncology Authors: Wenxi Huang Zanwen Zeng Yonghui Xu Zhibin Mai Source Type: research
Use of sirolimus as an adjuvant therapy for kidney transplant recipients with high-risk cutaneous squamous cell carcinomas: a prospective non-randomized controlled study
CONCLUSIONS: This study suggests that sirolimus monotherapy may be useful as adjuvant therapy of high-risk cSCC in kidney transplant recipients. The conversion strategy used was well tolerated and safe regarding key mid-term transplant outcomes.PMID:37565728 | DOI:10.1590/2175-8239-JBN-2023-0013en
Source: Jornal Brasileiro de Nefrologia - August 11, 2023 Category: Urology & Nephrology Authors: Marina Rezende de F ázio Marina Pontello Cristelli Jane Tomimori Carlos Eiji Koga Mar ília Marufuji Ogawa Giovanni Tani Beneventi Helio Tedesco-Silva Jos é Medina-Pestana Source Type: research
